The genetic basis of cardiovascular disease (CVD) with its complex etiology is still largely elusive. Plasma levels of lipids and apolipoproteins are among the major quantitative risk factors for CVD and are well-established intermediate traits that may be more accessible to genetic dissection than clinical CVD end points. Chromosome 19 harbors multiple genes that have been suggested to play a role in lipid metabolism and previous studies indicated the presence of a quantitative trait locus (QTL) for cholesterol levels in genetic isolates. To establish the relevance of genetic variation at chromosome 19 for plasma levels of lipids and apolipoproteins in the general, out-bred Caucasian population, we performed a linkage study in four independent samples, including adolescent Dutch twins and adult Dutch, Swedish and Australian twins totaling 493 dizygotic twin pairs. The average spacing of short-tandem-repeat markers was 6-8 cM. In the three adult twin samples, we found consistent evidence for linkage of chromosome 19 with LDL cholesterol levels (maximum LOD scores of 4.5, 1.7 and 2.1 in the Dutch, Swedish and Australian sample, respectively); no indication for linkage was observed in the adolescent Dutch twin sample. The QTL effects in the three adult samples were not significantly different and a simultaneous analysis of the samples increased the maximum LOD score to 5.7 at 60 cM pter. Bivariate analyses indicated that the putative LDL-C QTL also contributed to the variance in ApoB levels, consistent with the high genetic correlation between these phenotypes. Our study provides strong evidence for the presence of a QTL on chromosome 19 with a major effect on LDL-C plasma levels in outbred Caucasian populations.
Introduction
Dissecting the genetic basis of cardiovascular disease (CVD) is complicated by the etiologic heterogeneity of seemingly undistinguishable clinical end points. Major quantitative risk factors for CVD such as cholesterol levels may be more accessible to genetic dissection. 1 Also, individuals do not need to be classified as affected or unaffected for these quantitative variables, which often leads to ambiguous or uncertain phenotype assignment. Genes described to date that play a role in lipid metabolism have mainly been identified in familial lipid disorders, many of which are monogenic diseases. For example, defects in the genes encoding the low-density-lipoprotein-receptor (LDLR, 19p13.2) 2 and apolipoprotein B (APOB, 2p24) 3 are found to be responsible for the most common forms of familial hypercholesterolemia, and mutations in the ABC1 gene (9q31.1), encoding the cholesterol efflux regulatory protein, induce familial HDL cholesterol deficiency (Tangier's disease). 4 Although carriers of such mutations may develop severe disorders of lipid metabolism, these mutations explain only a minor proportion of the variation in plasma levels of lipids and apolipoproteins at the level of the general population. 5 The results of twin studies showing that 50 -80% of the population variation in levels of lipids and apolipoproteins is attributable to genetic factors 6, 7 thus imply that the majority of the genes determining these levels are still to be discovered. Compatible with this wealth of candidate genes, evidence for linkage with plasma levels of total cholesterol was found in Pima Indians and with LDL cholesterol levels in Hutterites. 14, 15 In contrast to the findings in these genetic isolates, however, no significant linkage with LDL-C levels on chromosome 19 was found in genome scans among outbred Caucasians. 16 -20 To gain insight into the effect of genetic variation on chromosome 19 on lipid metabolism in the general, Caucasian population, we performed a linkage study in four twin samples originating from The Netherlands, Sweden and Australia totaling 493 dizygotic twin pairs. To reduce genotyping errors, one known genotype was present on each gel, 5% of the genotypings were repeated and two independent individuals performed the allele calling. SIBMED 24 was used to identify unlikely double recombinants, the occurrence of which may be due to genotyping errors. After running SIBMED and checking the raw genotyping data, approximately 0.2% of the total genotypings appeared to be erroneous. Dependent on the error, these genotypes were changed in the right genotype or were set to missing.
Subjects and methods

Subjects
Statistical analysis
Allele frequencies were estimated separately for the twin samples using marker data for all individuals. 25 Plasma levels of triglycerides and apoE showed a skewed distribution and these values were therefore transformed by natural logarithm prior to analysis. The full distribution of multipoint identity-by-descent (IBD) sharing probabilities was estimated every centiMorgan across chromosome 19 using Genehunter 2.1. 26 Linkage analysis of quantitative traits was performed with variance components analysis using structural equation modeling with maximum likelihood implemented in the software Mx 1.52d. 27 The weighted likelihood approach, which makes use of the full distribution of IBD-probabilities, with adjustments for age and sex was used. 28 In a four-sample simultaneous analysis, IBD status for the DZ pairs was
Evidence for a QTL on chromosome 19 influencing LDL-C M Beekman et al estimated separately for each of the four samples in Genehunter 2.1 26 using population-specific allele frequencies. Mean LDL-C levels, background genetic and nonshared environmental effects were estimated for each sample separately. The absolute QTL effects were constrained to be equal over the different samples. Heterogeneity between the effects of the QTL in the different twin samples was tested by comparing the model estimating all parameters for the populations separately with the model in which the QTL effect was constrained to be equal. Bivariate analyses 29 were performed for correlated plasma levels of LDL-C and apoB.
Results
The characteristics of the adolescent Dutch and adult Dutch, Swedish and Australian dizygotic twins totaling 493 pairs are shown in Table 1 .
The four twin samples were analyzed using variance components analyses, which revealed a consistent indication for linkage with LDL cholesterol (LDL-C) levels ( Table 2 ). The maximum LOD scores (MLS) were 4.5, 1.7 and 2.1 in adult Dutch, Swedish and Australian twins, respectively; no linkage was observed in the adolescent Dutch twins. Lower levels of linkage were also observed for the LDL-C levels correlated phenotypes total cholesterol and apoB in the adult populations ( Table 2) .
As shown in Figure 1 , linkage in the adult twins samples was observed in the same chromosomal region suggesting that the same QTL may be involved. This was reinforced by the fact that the QTL effect was not significantly different in the three adult populations at the positions where the MLS were observed (P ¼ 0.50, 34 cM pter; P ¼ 0.13, 60 cM pter; P ¼ 0.06, 63 cM pter), whereas the QTL effect was significantly different in the adolescent Dutch population (eg P ¼ 0.0001, 60 cM pter). Therefore, the adult populations were combined in one linkage analysis including 410 dizygotic twin pairs (Figure 1 ). This analysis increased the MLS for LDL-C levels to 5.7 at 60 cM pter. Of the twin pairs that individually contributed more than 0.20 to the MLS, 62% (18/29) were Dutch, 17% (5/29) were Swedish and 21% (6/29) were Australian.
LDL-C and apoB levels are highly correlated phenotypes, both phenotypically (X0.79) and genetically (X0.79) (Table 3) indicating that genetic variation influencing LDL-C levels also influences apoB levels. Nevertheless, the MLSs were considerably higher for LDL-C levels than for apoB levels. To gain insight into the effect of the LDL-C QTL on apoB levels, we performed a bivariate linkage analysis of the two phenotypes at the position of MLS in the adult samples. Although the confidence intervals were wide and the estimates of the QTL effect not always significant (Table 3 ), this analysis showed that the putative QTL explained a considerable proportion of the variance in apoB levels in addition to that of LDL-C levels.
Discussion
We have studied chromosome 19 for linkage with intermediate lipid phenotypes of cardiovascular disease in dizygotic twin pairs from the general population of The Netherlands, Sweden and Australia. In all the adult twin samples, we found evidence for linkage of chromosome 19 with LDL-C levels with MLS ranging from 1.7 to 4.5. In spite of a large heritability of LDL cholesterol levels, which was previously estimated in the adolescent and adult twin samples between 0.60 and 0.85, 7 no indication for linkage was observed in the adolescent twin sample. This may be due to partly different effects of genes on lipid levels at different ages as suggested by Snieder et al 30 or to different gene -environment interaction on lipid levels at different ages as suggested by Zerba et al 31 The size of the QTL effect on LDL-C levels was not significantly different in the adult samples and a simultaneous analysis of these adult samples increased the LOD score to 5.7 at 60 cM from pter. This constitutes significant linkage according to the Lander - (Table 4) shows that, although the reported LOD scores for chromosome 19 are not significant, they are compatible with our findings. Linkage with LDL 1 -C levels in the San Antonio Heart Study (LOD ¼ 2.26) and with LDL 2 -C levels (LOD ¼ 1.86), 33 and linkage with total cholesterol levels in the Rochester Family Heart Study (LOD ¼ 1.14). 34 No suggestion for linkage with total cholesterol or LDL-C levels, however, was found in selected samples of myocardial infarction patients, type II diabetes patients and patients with familial combined hyperlipidemia. 16 -20 The LDL-C QTL on chromosome 19 thus constitutes one of the most replicated result from linkage studies, virtually ruling out the possibility that it is a false-positive observation.
The region in which we and other groups ( Figure 1 , Table 4 ) found evidence for linkage is broad, as is a general characteristic of results from twin and sib pair studies. QTL mapping in Drosophila melanogaster and Saccharomyces cerevisiae demonstrated that linkage results at a broad chromosomal region may be caused by several polymorphisms with a relatively small effect, which could be interpreted as one gene with a major effect. 35, 36 Possibly, several loci on chromosome 19 are influencing LDL cholesterol levels and perhaps different loci play major roles in Australian and European LDL cholesterol levels, which might explain the different locations of the MLS. However, the overall effect size of these loci is the not significantly different in Dutch, Swedish and Australians. The main candidates for underlying the LDL-C QTL on chromosome 19 (Table 4) are the APOE/C1/C4/C2 gene cluster and the LDLR and LRP3 gene loci. Apolipoprotein E is the major constituent of chylomicrons, VLDL and IDL particles and serves as ligand for the LDLR. When VLDL and IDL are not efficiently removed from the circulation by the LDLR, LDL particles will accumulate. The LDLR is also known to play an important role in the clearance of apoBcarrying-lipoproteins by the liver. 2, 37 Apolipoprotein C1 is a constituent of VLDL and HDL particles. It inhibits the lipoprotein lipase (LPL)-mediated hydrolysis of the triglycerides from VLDL, which leads to lower levels of LDL-C.
38
ApoC2 has the opposite effect on LDL-C levels, since it is an activator of LPL. 39 Although the function of apoC4 is unknown, there are some indications that it might play a role in lipid metabolism. 10, 40 The LRP3 is a family member of the LDLR. It is also expressed in the liver and it binds apoE-containing particles. The function of the LRP3 Evidence for a QTL on chromosome 19 influencing LDL-C M Beekman et al remains unclear, but as a family member of LDLR a role in lipid metabolism is assumed. 13 INSR and LIPE are candidates for influencing triglyceride levels, but not for LDL-C levels. 11, 12 Near the LDLR locus, the ATHS locus has been mapped involved in atherogenic lipoprotein phenotype pattern B, which is characterized by small, dense LDL particles, increased levels of triglycerides and decreased levels of HDL-C. 41 Since we have no indication for linkage with levels of triglycerides and HDL-C, we assume that the ATHS locus is a different locus than our LDL-C QTL.
In conclusion, we report strong and significant evidence for the presence of genetic variation at chromosome 19 with a major effect on LDL-C plasma levels in outbred Caucasian populations. Since high LDL-C level is a major risk factor for CVD, this finding may significantly contribute to disentangling the complex architecture of CVD. Candidate gene screening and the recently developed method for the combined analysis of linkage and association 42, 43 may reveal the genetic variation underlying the QTL. Table 3 Proportion of the total variance of LDL-C and ApoB explained by the putative QTL on the basis of bivariate analyses at the position of the maximum LOD score for LDL-C in the adult twin samples Evidence for a QTL on chromosome 19 influencing LDL-C M Beekman et al
